Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis.

L TorresEva KlingbergM NurkkalaH CarlstenH Forsblad-d'Elia

Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2018)

NCT00858819.

Keyphrases

growth factor
ankylosing spondylitis
postmenopausal women
bone mineral density
rheumatoid arthritis
disease activity
liver injury
drug induced
systemic lupus erythematosus
body composition